Your browser doesn't support javascript.
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.
Ganjali, Shiva; Bianconi, Vanessa; Penson, Peter E; Pirro, Matteo; Banach, Maciej; Watts, Gerald F; Sahebkar, Amirhossein.
  • Ganjali S; Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Bianconi V; Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
  • Penson PE; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
  • Pirro M; Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
  • Banach M; Department of Hypertension, Medical University of Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
  • Watts GF; Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Sahebkar A; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electr
Metabolism ; 113: 154375, 2020 12.
Article in English | MEDLINE | ID: covidwho-875889
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronary Artery Disease / Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Metabolism Year: 2020 Document Type: Article Affiliation country: J.metabol.2020.154375

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronary Artery Disease / Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Metabolism Year: 2020 Document Type: Article Affiliation country: J.metabol.2020.154375